Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
Clinical trial NCT00482508 · COMPLETED
Trial details
- NCT number
- NCT00482508
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2005-10-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.